Literature DB >> 2863680

Lytic infection by British AIDS virus and development of rapid cell test for antiviral antibodies.

A Karpas, W Gillson, P C Bevan, J K Oates.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2863680     DOI: 10.1016/s0140-6736(85)92934-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  14 in total

1.  A human myeloma cell line suitable for the generation of human monoclonal antibodies.

Authors:  A Karpas; A Dremucheva; B H Czepulkowski
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

2.  Can repeated plasma donation by asymptomatic HIV-infected individuals delay the onset of AIDS?

Authors:  D R Bainbridge; M W Lowdell; I M Hannet; K W Strauss; A Karpas
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1997-07-29       Impact factor: 6.237

3.  Inhibition of human immunodeficiency virus and growth of infected T cells by the immunosuppressive drugs cyclosporin A and FK 506.

Authors:  A Karpas; M Lowdell; S K Jacobson; F Hill
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-01       Impact factor: 11.205

4.  Postconditioning hormesis put in perspective: an overview of experimental and clinical studies.

Authors:  F A C Wiegant; H A B Prins; R Van Wijk
Journal:  Dose Response       Date:  2010-08-12       Impact factor: 2.658

5.  Measurement of antibodies to human immunodeficiency virus: an international collaborative study to evaluate WHO reference sera.

Authors:  A J Garrett; V Seagroatt; E M Supran; K O Habermehl; H Hampl; G C Schild
Journal:  Bull World Health Organ       Date:  1988       Impact factor: 9.408

6.  Rapid determination of neutralizing antibodies to Semliki Forest virus in serum by enzyme immunoassay in cell culture with virus-specific monoclonal antibodies.

Authors:  F H van Tiel; T Harmsen; M Wagenaar; W A Boere; C A Kraaijeveld; H Snippe
Journal:  J Clin Microbiol       Date:  1986-10       Impact factor: 5.948

7.  Effects of passive immunization in patients with the acquired immunodeficiency syndrome-related complex and acquired immunodeficiency syndrome.

Authors:  A Karpas; F Hill; M Youle; V Cullen; J Gray; N Byron; F Hayhoe; M Tenant-Flowers; L Howard; D Gilgen
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

8.  Aminosugar derivatives as potential anti-human immunodeficiency virus agents.

Authors:  A Karpas; G W Fleet; R A Dwek; S Petursson; S K Namgoong; N G Ramsden; G S Jacob; T W Rademacher
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

9.  Agreement study between two laboratories of immunofluorescence as a confirmatory test for human immunodeficiency virus type 1 antibody screening.

Authors:  J Mahony; K Rosenthal; M Chernesky; S Castriciano; E Scheid; M Blajchman; D Harnish
Journal:  J Clin Microbiol       Date:  1989-06       Impact factor: 5.948

10.  Studies of human retroviruses in relation to adult T-cell leukaemia, acquired immune deficiency syndrome, and multiple sclerosis.

Authors:  A Karpas; K Malik; J Lida
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.